C11orf42 and cancer: Consistently, we observed cytoplasmic signals for C11orf42 in 3/40 (8%) thyroid cancer samples on a commercial TMA (TH481), while 0/8 of the normal controls showed cellular staining (Figs S5D and 10C and cancer sample A3 versus normal sample F3 in panel D).